ICDcodes.org
FY2027

QA1.71Lynch syndrome

BillableNew in FY2027

Is QA1.71 billable?

Yes — QA1.71 is billable for FY2027. QA1.71 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. QA1.71 may be submitted for encounters from October 1, 2026 through September 30, 2027. QA1.71 is new in FY2027.

QA1.71 at a glance

CodeQA1.71
DescriptionLynch syndrome
BillableYes
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027
FY2027 changeNew in FY2027

Which MS-DRGs does QA1.71 group to?

QA1.71 sits in MDC 23 and helps define the logic of 1 MS-DRG (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.

  • 951Other Factors Influencing Health Statusmedical

How is QA1.71 listed in the Alphabetic Index?

These are the routes through the Alphabetic Index that lead to QA1.71. They show the wording a clinician may have documented, which often differs from the Tabular description.

  • Susceptibility to disease, genetichereditary nonpolyposis colorectal cancer
  • SyndromeLynch

Inclusion terms

Alternative wording in documentation that is classified to QA1.71.

  • Hereditary nonpolyposis colorectal cancer susceptibility
  • Lynch syndrome due to EPCAM
  • Lynch syndrome due to MLH1
  • Lynch syndrome due to MSH2
  • Lynch syndrome due to MSH6
  • Lynch syndrome due to PMS2

Excludes2 — not included here — inherited from Chapter 17

The conditions below are not part of QA1.71, but a patient may have both at the same time. When documentation supports it, QA1.71 and the excluded code may both be reported.

  • inborn errors of metabolism (E70-E88)

Excludes2 — not included here — inherited from QA1

The conditions below are not part of QA1.71, but a patient may have both at the same time. When documentation supports it, QA1.71 and the excluded code may both be reported.

  • multiple endocrine neoplasia [MEN] syndromes (E31.2-)

Code also — inherited from QA1

Two codes may be needed to describe the condition fully. Whether QA1.71 is sequenced first depends on the reason for the encounter.

  • , if applicable, any associated conditions, such as:
  • genetic susceptibility to malignant neoplasm by site (Z15.0-)
  • malignant neoplasms (C00.0-C96.9)
  • personal history of malignant neoplasm (Z85.-)

Which conditions are coded to QA1.71?

What other codes are in the QA1.7 family? (1)